Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University
Dhaka, Bangladesh
NCT Number: NCT01743066
To understand the pathogenesis of chronic arsenic toxicity, the investigators need to know the levels of vitamin E in patients chronically exposed to high concentration of arsenic and if changes are found, what happens when supplemented with vitamin E. The buccal cells and serum of patients will be collected for the estimation of vitamin E both before and after supplementation with vitamin E. Similar samples will be collected from similar number of arsenic exposed controls and healthy volunteers for comparison.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Dhaka, Bangladesh
Chronic consumption of arsenic through water (drinking and cooking) and food leads to accumulation of arsenic within the cell. We usually give emphasis on the skin manifestations (melanosis and keratosis) of arsenicosis that is diagnosed first. Other manifestations remain un-diagnosed or diagnosed later. The severe form is the development of cancer in different organs mainly skin, lungs and urinary bladder. To understand the pathophysiology of the development of clinical manifestations appearing in the skin first, we need to understand interior of cells other than skin. One of the dietary supplements, vitamin E is found to be effective in improving the clinical signs/symptoms of melanosis and keratosis. Buccal cells are also exposed to arsenic and easy to collect. To understand the pathogenesis, we need to know the levels of vitamin E in patients of arsenicosis and if changes, what happens when supplemented with vitamin E. The buccal cells and serum of 20 patients will be collected for the estimation of vitamin E both before and after supplementation with vitamin E (200 IU, caplet) daily orally for 20 weeks. Similar samples will be collected from 20 arsenic exposed controls and 20 healthy volunteers for comparison.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For arsenicosis
For arsenic exposed control
For healthy volunteers
Exclusion criteria
vitamin E (200 IU, caplet) daily orally for 20 weeks
Time frame: 0 week (baseline), 20 weeks (end)
Changes in the amount of vitamin E in buccal cells of arsenicosis patients, arsenic exposed controls and healthy volunteers will be estimated both before and after supplementation with vitamin E for 20 weeks.
Time frame: 0 week (baseline), 20 weeks (end)
Changes in the amount of cholesterol in buccal cells of arsenicosis patients, arsenic exposed controls and healthy volunteers will be estimated both before and after supplementation with vitamin E for 20 weeks.
Time frame: 0 week (baseline), 20 weeks (end)
Changes in the concentration of vitamin E in serum of arsenicosis patients, arsenic exposed controls and healthy volunteers will be estimated both before and after supplementation with vitamin E for 20 weeks.
Time frame: 0 week (baseline), 20 weeks (end)
Changes in the concentration of cholesterol in serum of arsenicosis patients, arsenic exposed controls and healthy volunteers will be estimated both before and after supplementation with vitamin E for 20 weeks.
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Other
Vitamin E Level in Buccal Cells of Arsenicosis Patients Following Vitamin E Supplementation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03127657
Chronic Arsenic Poisoning
Chāndpur, Bangladesh
View Trial DetailsNCT02908581
Chronic Arsenic Poisoning
Comilla, Bangladesh
View Trial DetailsNCT02352987
Chronic Arsenic Poisoning
Comilla, Bangladesh
View Trial DetailsNCT02468518
Chronic Arsenic Poisoning
Comilla, Bangladesh
View Trial Details